Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03280121 · ClinicalTrials.gov registry record · NA

Hernia Reduction Prior to Scheduled TIF Completion

A NA study, sponsored by EndoGastric Solutions.

Terminated
Registry status
NA
Development phase
14
Enrollment target

NCT03280121 is a NA study that was terminated before completion, run by EndoGastric Solutions. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03280121, a NA study, was terminated before completion, sponsored by EndoGastric Solutions.

TERMINATED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

Hernia Reduction Prior to Scheduled TIF Completion using EsophyX ZR transoral device

Interventions

  • DEVICE EsophyX ZR transoral device

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-10-05
Est. Completion 2020-10-26
Phase NA

Sponsor

EndoGastric Solutions

6 total trials

What the Registry Record Tells You About NCT03280121

The ClinicalTrials.gov registry entry for NCT03280121 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EndoGastric Solutions, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which EsophyX ZR transoral device is the first listed.

NCT03280121 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03280121 about?

NCT03280121 is a clinical study titled "Hernia Reduction Prior to Scheduled TIF Completion". Hernia Reduction Prior to Scheduled TIF Completion using EsophyX ZR transoral device

What is the current status of trial NCT03280121?

This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2018-10-05. Estimated completion is 2020-10-26.

What interventions are being tested in trial NCT03280121?

The interventions under investigation include: EsophyX ZR transoral device (DEVICE).

Who is sponsoring clinical trial NCT03280121?

This trial is sponsored by EndoGastric Solutions, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.